JP2004505993A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004505993A5 JP2004505993A5 JP2002518259A JP2002518259A JP2004505993A5 JP 2004505993 A5 JP2004505993 A5 JP 2004505993A5 JP 2002518259 A JP2002518259 A JP 2002518259A JP 2002518259 A JP2002518259 A JP 2002518259A JP 2004505993 A5 JP2004505993 A5 JP 2004505993A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence list
- list
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
【００７３】
【配列表】
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00202757A EP1178111A1 (en) | 2000-08-03 | 2000-08-03 | Vaccination against host cell-associated herpesviruses |
| PCT/EP2001/008893 WO2002012288A2 (en) | 2000-08-03 | 2001-08-01 | Vaccination against host cell-associated herpesviruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004505993A JP2004505993A (ja) | 2004-02-26 |
| JP2004505993A5 true JP2004505993A5 (ja) | 2005-03-03 |
| JP4313036B2 JP4313036B2 (ja) | 2009-08-12 |
Family
ID=8171884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002518259A Expired - Lifetime JP4313036B2 (ja) | 2000-08-03 | 2001-08-01 | 宿主細胞随伴性のヘルペスウイルスに対するワクチン接種 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9073979B2 (ja) |
| EP (2) | EP1178111A1 (ja) |
| JP (1) | JP4313036B2 (ja) |
| KR (1) | KR100633180B1 (ja) |
| CN (2) | CN102151333A (ja) |
| AT (1) | ATE412055T1 (ja) |
| AU (2) | AU2001291716B2 (ja) |
| BR (1) | BRPI0112989B1 (ja) |
| CA (1) | CA2417923C (ja) |
| CZ (1) | CZ303904B6 (ja) |
| DE (1) | DE60136278D1 (ja) |
| EA (1) | EA010721B1 (ja) |
| ES (1) | ES2315306T3 (ja) |
| HR (1) | HRP20030147B1 (ja) |
| HU (1) | HU228262B1 (ja) |
| IL (2) | IL154250A0 (ja) |
| MX (1) | MXPA03001027A (ja) |
| NO (1) | NO332621B1 (ja) |
| NZ (1) | NZ524066A (ja) |
| PL (1) | PL207958B1 (ja) |
| PT (1) | PT1307565E (ja) |
| UA (1) | UA84667C2 (ja) |
| WO (1) | WO2002012288A2 (ja) |
| ZA (1) | ZA200300842B (ja) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1178111A1 (en) | 2000-08-03 | 2002-02-06 | Lohmann Animal Health GmbH & Co. KG | Vaccination against host cell-associated herpesviruses |
| CA2558586A1 (en) * | 2004-03-05 | 2005-09-15 | The Research Foundation For Microbial Diseases Of Osaka University | Recombinant varicella-zoster virus |
| US9273326B2 (en) | 2004-04-30 | 2016-03-01 | The Brigham And Women's Hospital, Inc. | Tetracycline-regulated gene expression in HSV-1 vectors |
| US20080226677A1 (en) * | 2004-05-06 | 2008-09-18 | Yasuko Mori | Recombinant virus vector for gene transfer into lymphoid cells |
| ES2732815T3 (es) | 2009-05-22 | 2019-11-26 | Genocea Biosciences Inc | Vacunas frente al virus del herpes simple de tipo 2: composiciones y métodos para provocar una respuesta inmunitaria |
| SI2516629T1 (sl) | 2009-12-21 | 2016-10-28 | The Brigham And Women's Hospital, Inc. | Cepiva proti virusu herpes simplex |
| CA2856697A1 (en) * | 2010-11-24 | 2012-06-07 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| CA3206983A1 (en) * | 2011-10-21 | 2013-04-25 | Intervet International B.V. | Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens |
| JP6199878B2 (ja) * | 2011-11-23 | 2017-09-20 | ジェノセア バイオサイエンシーズ， インコーポレイテッド | 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法 |
| CN105561303B (zh) * | 2015-12-30 | 2019-04-05 | 暨南大学 | 单纯疱疹病毒i型ul5基因缺失的dna疫苗的制备方法 |
| CN105597095A (zh) * | 2015-12-30 | 2016-05-25 | 暨南大学 | 一种应用微载体培养Vero细胞制备基因缺失减毒疫苗的方法 |
| CN105641692A (zh) * | 2015-12-30 | 2016-06-08 | 暨南大学 | 单纯疱疹病毒ⅰ型基因重组减毒活疫苗及其制备方法 |
| JP2019537555A (ja) | 2016-09-28 | 2019-12-26 | ジェノセア バイオサイエンシーズ， インコーポレイテッド | ヘルペスを処置するための方法および組成物 |
| US11174322B2 (en) * | 2017-07-24 | 2021-11-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies and peptides to treat HCMV related diseases |
| MX2020006343A (es) * | 2017-12-20 | 2020-09-03 | Intervet Int Bv | Diluyente mejorado para vacuna de herpesvirus alfa asociado con celulas. |
| WO2019152821A1 (en) | 2018-02-05 | 2019-08-08 | The Brigham And Women's Hospital, Inc. | Recombinant herpes simplex virus-2 expressing glycoprotein b and d antigens |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959466A (en) * | 1974-04-15 | 1976-05-25 | The Wistar Institute | Highly attenuated cytomegalovirus vaccine and production thereof |
| GB8821441D0 (en) | 1988-09-13 | 1988-10-12 | Animal Health Inst | Viral vectors |
| EP0486106A3 (en) | 1990-11-16 | 1992-12-23 | Akzo N.V. | Marek's disease virus vaccine |
| AU657144B2 (en) * | 1991-07-09 | 1995-03-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
| JP3675569B2 (ja) | 1995-04-28 | 2005-07-27 | 日本ゼオン株式会社 | 組み換えウイルス及びそれよりなるワクチン |
| KR19990028766A (ko) | 1995-07-07 | 1999-04-15 | 나카노 가쓰히꼬 | 마렉 질환 바이러스 유전자 및 마렉 질환 예방용 백신에서그의 용도 |
| US6306387B1 (en) * | 1997-05-29 | 2001-10-23 | The Research Foundation Of State University Of New York | Antigen delivery system |
| DE19733364A1 (de) * | 1997-08-01 | 1999-02-04 | Koszinowski Ulrich H Prof | Verfahren zur Klonierung eines großen Virusgenoms |
| AUPP684998A0 (en) * | 1998-10-30 | 1998-11-26 | Murdoch Institute for Research into Birth Defects Limited, The | A method of recombination and agents useful for same |
| EP1038952A3 (en) | 1998-12-09 | 2001-06-27 | Pfizer Products Inc. | Processes for preparation of Marek's Disease Virus using continuous avian cell lines |
| US6410222B1 (en) * | 1998-12-14 | 2002-06-25 | Juridical Foundation The Chemosero-Therapeutic Research Institute | In ovo vaccination of marek's disease type I virus |
| US6299882B1 (en) | 1999-04-09 | 2001-10-09 | Schering Corporation | UL54.5 of Marek's disease virus (MDV) |
| EP1178111A1 (en) | 2000-08-03 | 2002-02-06 | Lohmann Animal Health GmbH & Co. KG | Vaccination against host cell-associated herpesviruses |
-
2000
- 2000-08-03 EP EP00202757A patent/EP1178111A1/en not_active Withdrawn
-
2001
- 2001-01-08 UA UA2003021829A patent/UA84667C2/ru unknown
- 2001-08-01 ES ES01971839T patent/ES2315306T3/es not_active Expired - Lifetime
- 2001-08-01 CA CA2417923A patent/CA2417923C/en not_active Expired - Lifetime
- 2001-08-01 AU AU2001291716A patent/AU2001291716B2/en not_active Ceased
- 2001-08-01 PT PT01971839T patent/PT1307565E/pt unknown
- 2001-08-01 KR KR1020037001366A patent/KR100633180B1/ko active IP Right Grant
- 2001-08-01 AU AU9171601A patent/AU9171601A/xx active Pending
- 2001-08-01 EA EA200300215A patent/EA010721B1/ru not_active IP Right Cessation
- 2001-08-01 CN CN2011100310998A patent/CN102151333A/zh active Pending
- 2001-08-01 DE DE60136278T patent/DE60136278D1/de not_active Expired - Lifetime
- 2001-08-01 AT AT01971839T patent/ATE412055T1/de active
- 2001-08-01 CN CNA018167950A patent/CN1503843A/zh active Pending
- 2001-08-01 IL IL15425001A patent/IL154250A0/xx unknown
- 2001-08-01 BR BRPI0112989A patent/BRPI0112989B1/pt active IP Right Grant
- 2001-08-01 EP EP01971839A patent/EP1307565B1/en not_active Expired - Lifetime
- 2001-08-01 PL PL365190A patent/PL207958B1/pl unknown
- 2001-08-01 CZ CZ20030324A patent/CZ303904B6/cs not_active IP Right Cessation
- 2001-08-01 WO PCT/EP2001/008893 patent/WO2002012288A2/en active IP Right Grant
- 2001-08-01 JP JP2002518259A patent/JP4313036B2/ja not_active Expired - Lifetime
- 2001-08-01 MX MXPA03001027A patent/MXPA03001027A/es active IP Right Grant
- 2001-08-01 NZ NZ524066A patent/NZ524066A/en not_active IP Right Cessation
- 2001-08-01 HU HU0302664A patent/HU228262B1/hu unknown
-
2003
- 2003-01-30 ZA ZA200300842A patent/ZA200300842B/en unknown
- 2003-01-30 US US10/354,932 patent/US9073979B2/en active Active
- 2003-02-02 IL IL154250A patent/IL154250A/en not_active IP Right Cessation
- 2003-02-03 NO NO20030524A patent/NO332621B1/no not_active IP Right Cessation
- 2003-02-28 HR HR20030147A patent/HRP20030147B1/xx not_active IP Right Cessation